The risk for intestinal necrosis with SPS is very low
August 1, 2022
Dr. Lippert Clinical question: What is the risk of intestinal necrosis with sodium polystyrene (SPS) for the treatment of hyperkalemia? Background: SPS is a medication that has been available...
Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACs
October 11, 2021
Corroborating previous studies, Iceland researchers report that rivaroxaban poses the highest risk of GI bleeding, compared with other DOACs.
Clostridioides difficile: Two sets of guidelines disagree
July 8, 2021
Clinicians may find themselves trying to reconcile conflicts between the American College of Gastroenterology and Infectious Diseases Society of America guidelines.
C. difficile guidelines offer new possibilities
June 24, 2021
Updated recommendations address issues of diagnosis, recurrence, and fecal microbial transplant.
Microbiome therapeutic offers durable protection against C. difficile recurrence
May 28, 2021
“The hope would be that one or more ... would probably replace the vast majority of FMT [procedures] that we do clinically,”said Dr. Sahil Khanna.
Antibiotics fail to improve colon ischemia outcomes
November 3, 2020
There were no differences in 30-day mortality between groups that received antibiotics and those that did not.
Diarrhea prevalent among COVID-19 patients with IBD
October 15, 2020
One in five patients with IBD and COVID-19 had diarrhea, at least twice the prevalence compared with pooled data from prior studies.
C. difficile linked to surgery risk in pediatric Crohn’s
October 14, 2020
Patients who tested positive for Clostridoides difficile in the first year after diagnosis were more likely to go in for colectomy.
Fecal transplant linked to reduced C. difficile mortality
October 14, 2020
A hospital’s switch to fecal transplants was associated with reduced mortality in patients with severe or fulminant Clostridioides difficile infection.
Real-world safety, efficacy found for fecal transplants
October 2, 2020
The study didn't yield any findings on indications other than Clostridioides difficile. "In no way, shape, or form does it mean you can use it for autism, depression, heart disease, or [irritable bowel syndrome]."